Skip to main content
Clinical Trials/CTRI/2021/11/037883
CTRI/2021/11/037883
Not yet recruiting
未知

Comparing the efficacy between oral Aprepitant and intravenous Ondansetron for prevention of post-operative nausea and vomiting in adult patients undergoing laparoscopic surgeries

JSS MEDICAL COLLEGE AND HOSPITA0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: O- Medical and Surgical
Sponsor
JSS MEDICAL COLLEGE AND HOSPITA
Status
Not yet recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
JSS MEDICAL COLLEGE AND HOSPITA

Eligibility Criteria

Inclusion Criteria

  • Adults of ASA Physical status class I/II aged 18\-60 years undergoing laparoscopic surgeries.

Exclusion Criteria

  • Patients already on treatment with anti\-emetics, steroid medication, or any other drug known to cause emesis currently or in the immediate past
  • Patients with known hypersensitivity to ondansetron or aprepitant
  • Pregnant or nursing mothers.
  • Hepatic, renal or cardiac insufficiency. Vomiting within 24 hours before surgery or of any organic aetiology.

Outcomes

Primary Outcomes

Not specified

Similar Trials